Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of a New Noise Reduction Strategy in Hearing Aids

NCT: NCT06138665 · COMPLETED

NCT IDNCT06138665
StatusCOMPLETED
Start Date2023-11-20
Completion2024-03-31
SponsorSonova AG (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this exploratory interventional study is to evaluate a new hearing aid noise-reduction strategy in experienced hearing aid users, compared to currently available strategies. The primary objective is to measure speech in noise performance with a new strategy and compare to the performance with currently available strategies via a coordinate response measure task.

Frequently Asked Questions

What is Evaluation of a New Noise Reduction Strategy in Hearing Aids?

Evaluation of a New Noise Reduction Strategy in Hearing Aids is a clinical trial registered under NCT06138665. Current status: COMPLETED.

What is the status of NCT06138665?

The current status of NCT06138665 (Evaluation of a New Noise Reduction Strategy in Hearing Aids) is: COMPLETED.

When did Evaluation of a New Noise Reduction Strategy in Hearing Aids start?

Evaluation of a New Noise Reduction Strategy in Hearing Aids started on 2023-11-20.

Related Devices

K230538All-Day Clear Slim ADCS1 Hearing Aid. All-Day Clear ADC1 Hearing AidSonova AG K232999Lyric4 Hearing AidSonova AG

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑